Finding out that your hemoglobin or hematocrit is high can be confusing, especially when you feel perfectly well. In some situations, elevated red blood cell levels need closer medical attention, and a physician may recommend therapeutic phlebotomy to remove a controlled amount of blood and bring those levels down.
For patients receiving testosterone, the issue deserves particular attention because testosterone can stimulate red blood cell production. That does not mean everyone using testosterone will develop high hemoglobin, nor does it mean testosterone therapy must automatically be stopped. It does mean that regular laboratory monitoring should be part of a responsible physician-guided hormone replacement therapy plan.
The more important question is not simply, “How do we lower the number?” It is, “Why is the number elevated in the first place?”
What Does High Hemoglobin Actually Mean?
Hemoglobin is the oxygen-carrying protein inside red blood cells. Hematocrit represents the percentage of your blood volume made up of red blood cells. The two measurements are closely related, which is why physicians often look at both when evaluating an abnormal complete blood count, or CBC.
When hemoglobin and hematocrit rise above the expected range, the condition may be described as erythrocytosis. You may also hear the word polycythemia, although polycythemia vera is a specific bone marrow disorder and should not be confused with every case of high hemoglobin.
An elevated result also needs context.
A person who is dehydrated, for example, may have less plasma—the liquid portion of blood—making the concentration of red blood cells appear higher even though the body has not actually produced an excessive number of them. Repeating laboratory testing after hydration or evaluating previous results can sometimes provide a clearer picture.
Persistent elevations require a different approach. The goal is to determine whether the body is producing too many red blood cells and, if so, what is driving that production.
Why Do Hemoglobin and Hematocrit Become Elevated?
There are many possible causes of erythrocytosis. Some originate in the bone marrow, while others occur because the body is responding to low oxygen levels, medication, hormones, or another physiological signal.
Common possibilities include:
- Testosterone replacement therapy or other androgen use
- Obstructive sleep apnea
- Cigarette smoking or significant carbon monoxide exposure
- Living at high altitude
- Chronic lung disease or certain heart conditions
- Dehydration and reduced plasma volume
- Certain kidney conditions that increase erythropoietin production
- Medications that affect red blood cell production
- Polycythemia vera and other less common blood disorders
This is why simply scheduling repeated phlebotomies without investigating the reason for the elevation can miss an important part of the picture.
A review of erythrocytosis published in the medical literature emphasizes that treatment of secondary erythrocytosis should generally be directed at the underlying cause, rather than using phlebotomy routinely for every elevated hematocrit.
At Ageless Forever, ongoing laboratory monitoring can also be incorporated into broader physician-guided preventive care. Patients who want more continuous medical oversight may benefit from the clinic's concierge medicine program, where laboratory trends, medications, hormone therapy, symptoms, and preventive health can be considered together.
How Does Therapeutic Phlebotomy Lower High Hemoglobin?
Therapeutic phlebotomy is fairly straightforward mechanically. A prescribed amount of blood is withdrawn through a vein, much like a standard blood donation.
The important difference is the reason for doing it.
A blood donation is performed to collect blood for potential use by another person. Therapeutic phlebotomy is a medical procedure ordered because removing blood may benefit the patient.
Removing whole blood immediately reduces the number of circulating red blood cells. As the body replaces the fluid portion of that blood, the concentration of red cells and the hematocrit decrease.
For some medical conditions, this is a well-established part of treatment.
Polycythemia vera is the clearest example. In this bone marrow disorder, controlling hematocrit is an important part of reducing thrombotic risk, and phlebotomy has long been a cornerstone of treatment. The evidence supporting phlebotomy in polycythemia vera should not, however, automatically be applied to every form of secondary erythrocytosis.
That distinction becomes especially relevant when high hematocrit develops during testosterone therapy.
Testosterone Therapy and High Hematocrit
Testosterone stimulates erythropoiesis—the process by which the body creates red blood cells. For many patients, this effect remains within the normal laboratory range. In others, hemoglobin and hematocrit can climb substantially.
Researchers believe testosterone influences red blood cell production through several mechanisms, including changes in erythropoietin signaling and reductions in hepcidin, an important regulator of iron metabolism.
Because of this known effect, hemoglobin and hematocrit should be monitored during testosterone treatment.
The Endocrine Society's testosterone therapy guideline identifies elevated hematocrit as an important consideration before and during treatment. Guidelines have commonly used a hematocrit around 54% as a level requiring intervention during testosterone therapy, although the appropriate response depends on the individual patient's situation.
Intervention does not necessarily mean scheduling phlebotomies indefinitely.
A physician may need to look at testosterone dose, blood levels, treatment formulation, dosing intervals, sleep apnea, smoking, hydration, pulmonary health and other factors that could be contributing to the rise.
Reducing or adjusting testosterone may be appropriate in some cases. Therapeutic phlebotomy may also be considered when clinically appropriate. The decision should be individualized rather than based on a single laboratory number.
A 2024 review of testosterone-induced erythrocytosis specifically cautioned that evidence supporting repeated therapeutic phlebotomy as a long-term solution for testosterone-induced erythrocytosis remains limited. The authors emphasized weighing the benefits and possible downsides rather than automatically relying on recurring blood removal.
That is an important distinction for anyone undergoing hormone optimization. Good management means monitoring the treatment itself, not simply treating a laboratory side effect while leaving the reason for it unchanged.
Why Repeated Phlebotomy Is Not Always the Whole Solution
Therapeutic phlebotomy can lower hematocrit effectively, but removing blood also removes iron.
Iron is required to manufacture hemoglobin and new red blood cells. With repeated phlebotomy, iron stores can gradually decline. In certain diseases, such as hereditary hemochromatosis, removing iron is one of the objectives of treatment. In someone undergoing phlebotomy primarily to control erythrocytosis, excessive iron depletion may be undesirable.
Low iron stores can contribute to fatigue, reduced exercise tolerance and other symptoms, even before severe anemia develops.
This is one reason the frequency of therapeutic phlebotomy should be based on a physician's evaluation rather than a fixed schedule that continues indefinitely.
Follow-up testing may include hemoglobin, hematocrit and, when clinically appropriate, iron-related markers such as ferritin. The exact testing depends on the patient's diagnosis, medical history and treatment plan.
Ageless Forever's Silver Wellness Program includes ongoing physician-guided wellness care and comprehensive blood work, which can be useful for patients who want to follow health markers over time rather than treating each laboratory result in isolation.
Can High Hemoglobin Cause Symptoms?
Mild erythrocytosis may produce no noticeable symptoms at all. Many people first learn about it after routine blood work.
When red blood cell concentrations become substantially elevated, some people may experience symptoms associated with changes in blood viscosity or the underlying condition causing the elevation. Headaches, dizziness, visual changes, unusual fatigue or a feeling of pressure may occur, although these symptoms are nonspecific and can have many other causes.
The presence or absence of symptoms does not tell the whole story. Someone with no symptoms can still have a laboratory abnormality worth investigating, while headaches or fatigue alone do not prove that high hematocrit is responsible.
New chest pain, significant shortness of breath, sudden weakness or numbness, difficulty speaking, severe neurological symptoms, or other signs of a possible cardiovascular or neurological emergency require immediate medical evaluation rather than waiting for a routine phlebotomy appointment.
What Happens During Therapeutic Phlebotomy?
The procedure generally resembles donating blood.
Before beginning, the clinical team may review your physician's order, recent blood work, blood pressure, pulse and current health status. A needle is placed in a vein, and the prescribed volume of blood is gradually removed.
Afterward, the needle is removed and the site is bandaged. Some patients are asked to remain seated briefly before leaving.
Temporary lightheadedness, fatigue, bruising or tenderness at the needle site can occur. Hydration before and after the procedure may be recommended when medically appropriate.
How often phlebotomy is needed varies considerably. Some patients require a series of procedures followed by less frequent monitoring. Others may only need an occasional procedure. In still other cases, managing the underlying cause may reduce or eliminate the need for continued phlebotomy.
There is no universal schedule that is appropriate for every patient with high hemoglobin.
Should You Donate Blood Instead?
Regular blood donation and therapeutic phlebotomy may look similar, but they are not interchangeable in every situation.
Blood donation centers have eligibility requirements designed around the safety of both the donor and the blood supply. A person who needs blood removed for a medical reason may not always qualify to donate, and a normal donation schedule may not match the treatment schedule prescribed by a physician.
Someone with persistently elevated hemoglobin also should not use routine blood donation as a substitute for determining why the level is high.
If your physician believes blood removal is medically necessary, therapeutic phlebotomy provides a controlled approach in which the amount removed and follow-up schedule can be based on your clinical needs.
High Hemoglobin Is a Signal to Look Deeper
Therapeutic phlebotomy can be an important tool for controlling elevated hemoglobin and hematocrit, but the laboratory result should not be viewed in isolation.
The first step is determining whether the elevation is temporary or persistent. From there, your physician can consider possible causes such as testosterone therapy, sleep apnea, smoking, dehydration, lung or heart disease, medication effects, kidney-related conditions or a primary blood disorder.
For patients using testosterone, this is also why ongoing blood work matters. Hormone optimization should involve more than reaching a target testosterone level. Treatment should be monitored over time so that changes in hematocrit, symptoms and other health markers can be addressed as part of the overall plan.
Ageless Forever offers physician-guided therapeutic phlebotomy in Las Vegas for patients when blood removal is medically appropriate. The amount removed and treatment frequency can be based on your laboratory results, medical history and physician's recommendations, with continued monitoring helping determine what should happen next.
If recent blood work shows elevated hemoglobin or hematocrit, the most useful next step is a medical evaluation that looks beyond the number and determines why it is elevated before deciding on the appropriate treatment.